Pharma Co. Duped Investors In $61M Offering, Suit Says
Tetraphase Pharmaceuticals Inc. withheld vital information from shareholders about the development of an experimental antibiotic when it issued a $61 million secondary public offering to fund a drug trial in July...To view the full article, register now.
Already a subscriber? Click here to view full article